Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,376
Total Claims
$2.7M
Drug Cost
1,077
Beneficiaries
$2,506
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
+95%
Cost per patient vs peers
$2,506 vs $1,283 avg
+117%
Brand preference vs peers
19.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
19
Opioid Claims
$177
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,743 claims · $2.4M
Generic: 11,390 claims · $316K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 544 | $508K |
| Denosumab | 180 | $292K |
| Sitagliptin Phosphate | 214 | $223K |
| Dulaglutide | 150 | $160K |
| Icosapent Ethyl | 248 | $148K |
| Lipase/Protease/Amylase | 108 | $140K |
| Semaglutide | 118 | $137K |
| Dapagliflozin Propanediol | 95 | $76K |
| Linagliptin | 65 | $74K |
| Insulin Glargine,hum.Rec.Anlog | 135 | $66K |
| Sevelamer Carbonate | 27 | $48K |
| Linaclotide | 66 | $45K |
| Insulin Lispro | 69 | $39K |
| Insulin Aspart | 38 | $31K |
| Icosapent Ethyl | 56 | $31K |
Prescribing Profile
Patient Profile
73
Avg Age
50%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About